Evidence map›Paper›PMID 18828177›Full record

ArticleBiotechnology and bioengineering2009

Production, purification, and characterization of human alpha1 proteinase inhibitor from Aspergillus niger.

Liat Chill, Loc Trinh, Parastoo Azadi, Mayumi Ishihara, Roberto Sonon, Elena Karnaukhova, Yakir Ophir, Basil Golding, Joseph Shiloach

Open access · greenAbstract read
In one paragraph

Article in Biotechnology and bioengineering, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Enhancement of Alpha 1-antitrypsin Production inIranian journal of biotechnology · 2017
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Liat ChillBiotechnology Core Laboratory, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Building 14A Room 170, 9000 Rockville Pike, Bethesda, Maryland 20892, USA.
Loc Trinh
Parastoo Azadi
Mayumi Ishihara
Roberto Sonon
Elena Karnaukhova
Yakir Ophir
Basil Golding
Joseph Shiloach
Center for Biologics Evaluation and Research · USNational Institute of Diabetes and Digestive and Kidney Diseases · USUniversity of Georgia · USAnalytical Services · US

Funding

Production and purification of biological compoundsZICDK015500 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI SHILOACH, JOSEPH · 2009 to 2022
$7.2M
LARGE-SCALE PRODUCTION &PURIFICATION OF COMPOUNDS WITH BIOLOGICAL ACTIVITYZ01DK015500 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI SHILOACH, JOSEPH · 1986 to 2008
$568k
Intramural NIH HHS ZIC DK015500
6 · The paper itself

Abstract

Human alpha one proteinase inhibitor (alpha1-PI) was cloned and expressed in Aspergillus niger, filamentious fungus that can grow in defined media and can perform glycosylation. Submerged culture conditions were established using starch as carbon source, 30% dissolved oxygen concentration, pH 7.0 and 28 degrees C. Eight milligrams per liter of active alpha1-PI were secreted to the growth media in about 40 h. Controlling the protein proteolysis was found to be an important factor in the production. The effects of various carbon sources, pH and temperature on the production and stability of the protein were tested and the product was purified and characterized. Two molecular weights variants of the recombinant alpha1-PI were produced by the fungus; the difference is attributed to the glycosylated part of the molecule. The two glycoproteins were treated with PNGAse F and the released glycans were analyzed by HPAEC, MALDI/TOF-MS, NSI-MS(n), and GC-MS. The MALDI and NSI- full MS spectra of permethylated N-glycans revealed that the N-glycans of both variants contain a series of high-mannose type glycans with 5-20 hexose units. Monosaccharide analysis showed that these were composed of N-acetylglucos-amine, mannose, and galactose. Linkage analysis revealed that the galactosyl component was in the furanoic conformation, which was attaching in a terminal non-reducing position. The Galactofuranose-containing high-mannnose type N-glycans are typical structures, which recently have been found as part of several glycoproteins produced by Aspergillus niger.

Indexed as

alpha 1-AntitrypsinAmino Acid SequenceAspergillus nigerBiomassBioreactorsCarbohydrate ConformationCarbohydrate MetabolismCarbohydratesCloning, MolecularElectrophoresis, Polyacrylamide GelGlycosylationHumansHydrogen-Ion ConcentrationPeptide MappingPeptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine AmidasePolysaccharidesalpha 1-AntitrypsinCarbohydratesPeptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine AmidasePolysaccharidesRecombinant Proteins

Identifiers

PMID18828177
PMCPMC9536132
OpenAlexW2012444076

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.